Rodman David Malcom sold MLYS
June 10, 2026 · Form 4 insider transaction
Rodman David Malcom sold 2,170 shares of Mineralys Therapeutics, Inc. at $25.00 per share, a transaction worth $54.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,170
Price
$25.00
Total value
$54.3K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 10, 2026
Filing dateJune 12, 2026
Shares owned after63,443
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.